0001104659-16-162354.txt : 20161215 0001104659-16-162354.hdr.sgml : 20161215 20161215171536 ACCESSION NUMBER: 0001104659-16-162354 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161215 DATE AS OF CHANGE: 20161215 EFFECTIVENESS DATE: 20161215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001614067 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320074500 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-276429 FILM NUMBER: 162054431 BUSINESS ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 BUSINESS PHONE: (408) 385-1742 MAIL ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 D 1 primary_doc.xml X0707 D LIVE 0001614067 Aridis Pharmaceuticals, Inc. 5941 Optical Court San Jose CA CALIFORNIA 95138 408-385-1742 DELAWARE Aridis Pharmaceuticals LLC None Corporation true Vu Troung 5941 Optical Court San Jose CA CALIFORNIA 95138 Executive Officer Director Chief Executive Officer, Director Eric Patzer 5941 Optical Court San Jose CA CALIFORNIA 95138 Executive Officer Director Secretary, Chairman of the Board of Directors Fred Kurland 5941 Optical Court San Jose CA CALIFORNIA 95138 Executive Officer Chief Financial Officer Paul-Andre de Lame 5941 Optical Court San Jose CA CALIFORNIA 95138 Executive Officer Chief Medical Officer Robert Coughlin 5941 Optical Court San Jose CA CALIFORNIA 95138 Director Craig Gibbs 5941 Optical Court San Jose CA CALIFORNIA 95138 Director John Hamilton 5941 Optical Court San Jose CA CALIFORNIA 95138 Director Robert Ruffolo, Jr. 5941 Optical Court San Jose CA CALIFORNIA 95138 Director Isaac Blech 5941 Optical Court San Jose CA CALIFORNIA 95138 Director Vice Chairman Pharmaceuticals Decline to Disclose 06b false 2016-12-12 false true true true false 25000 Maxim Merchant Capital, a division of Maxim Group LLC 120708 None None 405 Lexington Avenue New York NY NEW YORK 10174 AL ALABAMA AZ ARIZONA CA CALIFORNIA DC DISTRICT OF COLUMBIA FL FLORIDA IL ILLINOIS MN MINNESOTA NV NEVADA NM NEW MEXICO NY NEW YORK TX TEXAS 25000000 13642707 11357293 false 14 1364270 0 The placement agent will also recieve a warrant to purchase Series A Convertible Preferred Stock or common stock at the same exercise price as investors. 0 false Aridis Pharmaceuticals, Inc. /s/ Vu Truong Vu Truong Chief Executive Officer 2016-12-15